Mark Braden, DO
Neuromusculoskeletal Medicine & OMM · Grand Rapids, MINPI 1912490905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 527 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Johnson & Johnson at 28.9% of the total. Among neuromusculoskeletal medicine & omm clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 527 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- UCB, Inc.$1K
- Amgen$1K
- ANI Pharmaceuticals, Inc.$558
- AstraZeneca$519
- Mallinckrodt Hospital Products Inc.$430
- plus $2K from 24 others
What the payments were for
- Food & beverage$7,73698%
- Education$1902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 248 | $2,289 |
| UCB, Inc. | 56 | $1,150 |
| Amgen | 71 | $1,116 |
| ANI Pharmaceuticals, Inc. | 25 | $558 |
| AstraZeneca(2 entities) | 25 | $519 |
| Mallinckrodt Hospital Products Inc. | 19 | $430 |
| Lilly USA, LLC | 13 | $274 |
| Organon | 11 | $225 |
| Boehringer Ingelheim | 9 | $187 |
| Janssen Scientific Affairs, LLC | 2 | $184 |
| Novartis | 3 | $123 |
| Merck | 4 | $97 |
| Radius Health, Inc. | 6 | $96 |
| Sandoz | 4 | $84 |
| Sobi, Inc | 4 | $71 |
| AbbVie | 3 | $61 |
| Aurinia Pharma U.S., Inc. | 3 | $61 |
| Kyowa Kirin, Inc. | 3 | $58 |
| Alvogen Inc | 3 | $54 |
| Pfizer | 3 | $51 |
| Sanofi | 2 | $37 |
| Fresenius Kabi USA, LLC | 1 | $33 |
| Bioventus LLC | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| United Therapeutics Corporation | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Biocon Biologics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$112
- PURIFIED CORTROPHIN GEL$101
How this compares
$7,926 in reported general payments places this provider in the 95th percentile of 41 neuromusculoskeletal medicine & omm providers in Michigan.
See all neuromusculoskeletal medicine & omm providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuromusculoskeletal medicine & omm in Grand Rapids
- Kevin HayesGrand Rapids$179
- Kyle McDonaldGrand Rapids$17
- Derek RosolGrand Rapids$16
- Max FeinsteinBloomfield Hills$8K
- Sidney BroderGrand Blanc$2K
- Reddog SinaEast Lansing$1K
- Mark BeardNovi$533
- David NebbelingLansing$479
- David HicklingClinton Twp$477
- Zachary WilsonEast Lansing$448
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.